Get started
Author

Sophie Roche

Observed names: S. Roche, Sophie ROCHE
Institution: Centre Jean Bernard
Observed institutions: University of Oxford, Centre Jean Bernard, St Pancras Hospital, Clinique Victor Hugo, Jenner Institute, North London NHS Foundation Trust, University College London
ORCID: 0000-0001-6751-0636
Observed ORCID: 0000-0001-6751-0636
OpenAlex ID: A5025404626
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
2020 · Merryn Voysey, Sue Ann Costa Clemens, et al. · The Lancet · 4,722
PDF
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
2020 · Pedro M Folegatti, Katie J Ewer, et al. · The Lancet · 2,439
PDF
Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine
2021 · Merryn Voysey, Sue Ann Costa Clemens, et al. · The Lancet · 1,132
PDF
Infection and mortality of healthcare workers worldwide from COVID-19: a systematic review
2020 · Soham Bandyopadhyay, Ronnie E Baticulon, et al. · BMJ Global Health · 737
PDF
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
2020 · Katie J. Ewer, Jordan R. Barrett, et al. · Nature Medicine · 590
PDF
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
2020 · Jordan R. Barrett, Sandra Belij-Rammerstorfer, et al. · Nature Medicine · 312
PDF
Use of Metabolic Parameters as Prognostic Factors During Concomitant Chemoradiotherapy for Locally Advanced Cervical Cancer
2016 · Samar Krhili, Jean-Pierre Muratet, et al. · American Journal of Clinical Oncology · 27
Results of PONDx, a prospective multicenter study of the Oncotype DX® breast cancer assay: Real-life utilization and decision impact in French clinical practice
2019 · Elsa Curtit, Jean-Michel Vannetzel, et al. · The Breast · 19
Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
2021 · Jordan R. Barrett, Sandra Belij-Rammerstorfer, et al. · Nature Medicine · 15
PDF
Lymphocytopaenia is associated with severe SARS-CoV-2 disease: A Systematic Review and Meta-Analysis of Clinical Data
2020 · Robin Brown, Jane Barnard, et al. · medRxiv · 15
PDF
Maintenance olaparib after platinum-based chemotherapy for advanced/metastatic endometrial cancer: GINECO randomized phase IIb UTOLA trial
2025 · Florence Joly, Alexandra Leary, et al. · Nature Communications · 14
PDF
Cross-sectional Survey of Medical student Attitudes to Research and Training pathways (SMART) in the UK: study protocol
2021 · Sophie Roche, Soham Bandyopadhyay, et al. · BMJ Open · 12
PDF
Real-world dostarlimab use in advanced/recurrent endometrial cancer in France
2023 · Manuel Rodrigues, Lauriane Eberst, et al. · Bulletin du Cancer · 9
Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
2021 · Katie J. Ewer, Jordan R. Barrett, et al. · Nature Medicine · 7
PDF
Incidental findings in UK healthy volunteers screened for a COVID‐19 vaccine trial
2021 · Susanne H. Hodgson, Poppy Iveson, et al. · Clinical and Translational Science · 4
PDF
2022-RA-922-ESGO Histo-molecular characteristics of platinum-sensitive advanced endometrial cancer: data issued from the population included in the GINECO UTOLA study
2022 · Florence Joly, Pierre Alexandre Just, et al. · International Journal of Gynecological Cancer · 2
PDF
Characterization of Proficient Mismatch Repair Endometrial Cancer Subpopulation of the Randomized Phase Ii Gineco-utola Study
2026 · Francois Cherifi, Raphaël Leman, et al. · International Journal of Gynecological Cancer
Systematic review and meta‐analysis of antipsychotic discontinuation in dementia
2025 · Sophie Roche, Nimesh Naran, et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions
PDF
Characterization Of The PMMR Advanced Endometrial Cancer Subpopulation Of The Randomized Phase II GINECO-UTOLA Study
2025 · François Cherifi, Raphael Leman, et al. · International Journal of Gynecological Cancer
41MO ESR1 mutation in untreated endometrial cancer: Prevalence, characteristics and prognostic implications from the UTOLA trial
2024 · F. Blanc-Durand, S. Nikolaev, et al. · ESMO Open
PDF
Sarcopenia in metastatic cancer patients: results of a prospective non-randomized study.
2021 · Jonas DUBU, Anne-Lise SEPTANS, et al. · Research Square
PDF
EP-1391: Digestive toxicity after conformal radiotherapy for palliative cervico-thoracic spinal metastases
2017 · G. Peyraga, D. Caron, et al. · Radiotherapy and Oncology
PDF
Works count: 22
Citation count: 10,060
H-index: 12
I10-index: 12
Year
Topic
Type